
In a significant win for independent pharmacies, Health Law Alliance has secured the dismissal of a lawsuit filed by Cardinal Health, Inc. (Cardinal), a multinational corporation, against our clients, several independent pharmacies and pharmacy owners located in Texas, New Jersey, and New York. The United States District Court for the Southern District of Ohio granted dismissal of Cardinal’s amended complaint pursuant to Rule 41(a)(2) of the Federal Rules of Civil Procedure.
The dismissal comes after Health Law Alliance filed a comprehensive motion to dismiss, challenging the merits of Cardinal's case. Our motion argued that the Court lacked personal jurisdiction over the defendants, that Cardinal had failed to state a valid claim for relief, and that the defendants were improperly joined together in a single lawsuit.
Cardinal filed its original complaint last December in state court in Ohio, positing baseless allegations of breach of contract, fraudulent inducement, and conspiracy by Defendants, arising out of their Independent Pharmacy Returns Program. After the case was removed to federal court, Health Law Alliance moved to dismiss the complaint. After numerous stalling attempts to stave off dismissal of its baseless action, Cardinal finally voluntarily consented to dismissal of its complaint by the Court.

This lawsuit represents a classic example of a large corporation attempting to leverage its size and resources to intimidate and extract profits from smaller, independent pharmacies. Cardinal Health, headquartered in Dublin, Ohio, engaged in blatant forum shopping, filing the lawsuit in its home state in an attempt to gain an unfair advantage. This calculated move was designed to inconvenience and financially strain the defendants, who are located hundreds of miles away, in the hopes of forcing a quick settlement and boosting their shareholder value. Cardinal’s complaint attempted to lump together a disparate group of defendants in a baseless legal action. Our attorneys meticulously dismantled Cardinal Health's arguments, exposing the complaint's deficiencies and the plaintiff's transparent attempt to manipulate the legal system.
The voluntary dismissal by Cardinal Health after our motion to dismiss was filed speaks volumes. It is a tacit admission of the weakness of their case and a victory for every independent pharmacy that has been targeted by the predatory tactics of pharmaceutical wholesalers.
This outcome is not just a win for our clients; it is a testament to the principle that justice is not determined by the size of a litigant's bank account. Health Law Alliance remains steadfast in its commitment to defending the rights of healthcare providers and suppliers against the overreach of powerful corporations and government agencies. We are proud to have delivered this result for our clients, and will continue to fight to ensure a level playing field for businesses in the healthcare industry.
MORE ARTICLES BY CATEGORY
Guidance for New Entrants on Navigating PBM Audit Complexities
New pharmacy owners face complex PBM audit requirements that demand strict documentation, accurate claims, and ongoing compliance. Establishing strong recordkeeping systems and proactive audit readiness can help prevent costly recoupments and protect long-term network participation.
Read More >>How Pharmacies Can Challenge Unfair PBM Audit Findings
PBM audits can leave pharmacies facing exaggerated findings, steep recoupments, and even network termination. With the right strategies and legal support, pharmacies can successfully challenge unfair results and protect their business.
Read More >>Top Red Flags That May Trigger a PBM Audit
PBM audits can be disruptive, costly, and often triggered by high prescription volumes, dispensing irregularities, or claim activity. Pharmacies can reduce risks through strong documentation, compliance, and legal support to challenge unfair findings and protect network status.
Read More >>Approaching the Telehealth Policy Cliff: Medicare Telehealth Flexibilities to Expire Next Week
Without further congressional action, COVID-19 era telehealth flexibilities are set to expire on September 30, 2025. Read more to learn about what’s set to change and key guidance for telehealth providers to prepare to adapt to pre-pandemic coverage rules.
Read More >>